The present invention provides a protein-based biomarker, Protein C Inhibitor (PCI) that is useful in qualifying prostate cancer status in a patient. In particular, the biomarker of this invention is useful to classify a subject sample as prostate cancer or non- prostate cancer. The biomarker can be detected by SELDI mass spectrometry.
申请公布号
WO2007035766(A3)
申请公布日期
2007.12.21
申请号
WO2006US36538
申请日期
2006.09.19
申请人
THE JOHNS HOPKINS UNIVERSITY;ZHANG, ZHEN;CHAN, DANIEL, W.;ROSENZWEIG, CAROLYN, N.
发明人
ZHANG, ZHEN;CHAN, DANIEL, W.;ROSENZWEIG, CAROLYN, N.
